146 West River Street
3rd Floor, Suite 11-D
Providence, RI 02904Directions
Schedule an appointment
Meet Our Providers Forms for Patients
Access Your Patient Portal Portal questions,
Christina A. Bandera, MD, is a gynecologic oncologist and director of the Center for Gynecologic Cancers at the Women’s Medicine Collaborative, and chief of obstetrics and gynecology at The Miriam Hospital and Rhode Island Hospital. Bandera received her undergraduate degree from Harvard University, and her medical degree from Johns Hopkins University School of Medicine. She completed her postgraduate training at Brigham & Women’s Hospital and Massachusetts General Hospital, and held fellowships at the University of Pennsylvania School of Medicine and the Mayo Clinic Hospital in Phoenix, Arizona. Bandera is board certified in obstetrics and gynecology, and gynecologic oncology.
She served as director of robotic surgery at Women & Infants Hospital. She is a member of the Society of Gynecologic Oncologists and the American Association for Gynecologic Laparoscopy. Bandera’s clinical expertise includes the medical and surgical treatment of gynecologic cancers arising from the uterus, ovary, cervix, vagina and vulva, as well as the treatment of molar pregnancies and conditions resulting in abnormal pap smears. She has a special interest in cancer prevention and minimally invasive cancer surgery, including robotic surgery.
Mary Artery, ANP-BC, AOCN, is a nurse practitioner in gynecologic oncology in the Center for Gynecologic Cancers at the Women’s Medicine Collaborative. She received her undergraduate degree in nursing from the University of Rhode Island, and a master of science in health services from Northeastern University. She is certified in advanced oncology and in cancer survivorship, training and rehabilitation (STAR), as well as by the American Nurses Credentialing Center.
She has 15 years of experience working with oncology patients at Memorial, Massachusetts General, and Women & Infants hospitals. Her clinical subspecialties include breast disease and gynecologic oncology.
Amy Pilotte, MSN, ANP-BC, is a nurse practitioner in the Women’s Cancer Survivorship Medicine Program at the Women’s Medicine Collaborative. She received an undergraduate degree in health care administration at Stonehill College in Easton, Massachusetts, and her master of science degree in nursing at the Massachusetts General Hospital Institute of Health Professions in Boston. She is currently working toward her certification in palliative care.
Her past clinical experience includes her role as a nurse practitioner in the Sarcoma Center at the Dana-Farber Cancer Institute in Boston. In addition to direct patient care, in collaboration with comprehensive care teams, a large focus of Amy’s role was on patient education, palliative care, pain management, emotional support and cancer survivorship.
Pilotte is a board certified adult nurse practitioner and is certified by the American Nurses Credentialing Center. Her clinical and research interests include cancer management, side effects, optimizing safety, and the patient’s experience in clinical trials.
Chanika Phornphutkul, MD, is an affiliated physician in the Cancer Survivorship Medicine Program at the Women’s Medicine Collaborative. She and her team of genetic counselors participate in the evaluation and genetic risk assessment as well as counseling for women with a personal or family history of genetic disorders. She is an associate professor of pediatrics at The Warren Alpert Medical School of Brown University. She is director of the division of human genetics at Hasbro Children’s Hospital and Rhode Island Hospital.
Phornphutkul completed her undergraduate and medical school degrees at the Chiang Mai University School of Medicine in Thailand, and did her postgraduate training at the University of Michigan, Brown University, and at the National Human Genome Research Institute at the National Institutes of Health in Bethesda, Maryland.
Her clinical and research interests focus on biochemical genetics (metabolic disorders), the application of genomic information in clinical medicine and newborn screening.